MARKET

CPIX

CPIX

Cumberland Pharmaceuticals Inc
NASDAQ
2.410
-0.080
-3.21%
After Hours: 2.410 0 0.00% 16:00 09/30 EDT
OPEN
2.440
PREV CLOSE
2.490
HIGH
2.610
LOW
2.340
VOLUME
6.79K
TURNOVER
0
52 WEEK HIGH
7.51
52 WEEK LOW
1.890
MARKET CAP
35.34M
P/E (TTM)
-4.1302
1D
5D
1M
3M
1Y
5Y
$3 Million Bet On This Communication Services Stock? Check Out These 4 Penny Stocks Insiders Are Buying
The Dow Jones dropped more than 290 points on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Benzinga · 08/22 15:08
Cumberland Q2 EPS $(0.01), Sales $10.30M Beat $9.19M Estimate
Cumberland (NASDAQ:CPIX) reported quarterly losses of $(0.01) per share. The company reported quarterly sales of $10.30 million which beat the analyst consensus estimate of $9.19 million by 12.08 percent. This is a
Benzinga · 08/09 21:17
Cumberland Pharmaceuticals Non-GAAP EPS of -$0.01, revenue of $10.3M
Cumberland Pharmaceuticals press release (...
Seekingalpha · 08/09 20:38
-- Earnings Flash (CPIX) CUMBERLAND PHARMACEUTICALS Reports Q2 Revenue $10.3M
-- Earnings Flash (CPIX) CUMBERLAND PHARMACEUTICALS Reports Q2 Revenue $10.3M
MT Newswires · 08/09 16:21
Cumberland Pharmaceuticals Reports 2.4m Patient Doses Delivered, No Product Recalls, No FDA Issues In 2021
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX), a specialty pharmaceutical company, today released its 2021 Sustainability Report detailing its activities regarding its involvement in environmental, social and governance
Benzinga · 08/08 13:26
CUMBERLAND PHARMACEUTICALS REPORTS 2.4M PATIENT DOSES DELIVERED, NO PRODUCT RECALLS, NO FDA ISSUES IN 2021
Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, today released its 2021 Sustainability Report detailing its activities regarding its involvement in environmental, social and governance matters.
PR Newswire · 08/08 13:25
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE SECOND QUARTER 2022 FINANCIAL RESULTS
Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, announced today that it will release its second quarter 2022 financial results and provide a company update after the market closes on Tuesday, Aug. 9, 2022.
PR Newswire · 08/02 20:05
BRIEF-Cumberland Pharmaceuticals Appoints Martin Brown Jr. To Board
BRIEF-Cumberland Pharmaceuticals Appoints Martin Brown Jr. To Board
Reuters · 07/19 13:32
More
About CPIX
Cumberland Pharmaceuticals Inc. is a specialty pharmaceutical company that is focused on the acquisition, development, and commercialization of prescription pharmaceutical products. Its portfolio of brands includes Acetadote injection, for the treatment of acetaminophen poisoning; Caldolor injection, for the treatment of pain and fever; Kristalose for oral solution, a prescription laxative, for the treatment of constipation; and Omeclamox-Pak for the treatment of Helicobacter pylori (H. pylori) infection and related duodenal ulcer disease. Its brands also include RediTrex injection, for the treatment of active rheumatoid, juvenile idiopathic and severe psoriatic arthritis, as well as disabling psoriasis; Sancuso transdermal system, for the prevention of nausea and vomiting in patients receiving certain types of chemotherapy treatment; Vaprisol injection, to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia; and Vibativ injection.

Webull offers kinds of Cumberland Pharmaceuticals, Inc. stock information, including NASDAQ:CPIX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CPIX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CPIX stock methods without spending real money on the virtual paper trading platform.